IP Library Granted Patent US 8,309,795
Granted Patent B2
US 8,309,795 · App. 12/836,925 · Granted Nov 13, 2012

Method for secretory production of glycoprotein having human-type sugar chain using plant cell

Assignee: Phyton Holdings, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,309,795
App. No.
12/836,925
Granted
Nov 13, 2012
Kind
B2
Abstract

A method for the secretory production of a glycoprotein having a human-type sugar chain, comprising a step of introducing a gene of an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine residue, and a gene of heterologous glycoprotein, to obtain a transformed plant cell, a step of culturing the plant cell, and a step of recovering the culture medium of the plant cell.

Claims (16)

1. A method for the secretory production of a glycoprotein having a human-type sugar chain from a plant cell, the method comprising:

a) introducing into said plant cell a first heterologous nucleic acid sequence encoding an enzyme that is capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine reside;

b) introducing into said plant cell a second nucleic acid sequence encoding a heterologous glycoprotein; and,

c) culturing said plant cell such that the heterologous glycoprotein is secreted from said plant cell.

2. The method of claim 1 , wherein said heterologous glycoprotein comprises a core sugar chain and an outer sugar chain, said core sugar chain comprises a plurality of mannose and acetylglucosamines, and said outer sugar chain comprises a terminal sugar chain moiety containing a non-reducing terminal galactose.

3. The method of claim 2 wherein said outer sugar chain has a linear structure.

4. The method of claim 2 wherein said outer sugar chain has a branched structure.

5. The method of claim 4 wherein said branched outer sugar chain is a mono-, bi, tri, or tetra-structure.

6. The method of claim 1 wherein said glycoprotein is free of fucose or xylose.

7. The method of claim 1 further comprising a step of recovering the secreted glycoprotein.

8. A transgenic plant cell comprising a first introduced nucleic acid sequence encoding an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine and a second introduced nucleic acid sequence encoding a heterologous glycoprotein, wherein said enzyme adds a galactose residue to a glycoprotein comprising a core sugar chain and an outer sugar chain, said core sugar chain substantially comprises a plurality of mannoses and acetylglucosamines, and said outer sugar chain has a terminal sugar chain moiety containing a non-reducing terminal galactose and wherein said transgenic plant cell secretes said heterologous glycoprotein.

9. A transgenic plant cell according to claim 8 wherein said heterologous glycoprotein comprises a galactose residue.

10. A transgenic plant cell according to claim 8 wherein said heterologous glycoprotein is free of β1,2 xylose or α1,3 fucose.

11. A transgenic plant cell according to claim 8 wherein said heterologous glycoprotein comprises a galactose residue added to an N-linked sugar of (N-acetylglucosamine) 1-2 (Mannose) 2-5 (N-acetylglucosamine) 2 selected from the group consisting of GlcNAc 1 Man 3 GlcNAc 2 , GlcNAc 1 Man 5 GlcNAc 2 , GlcNAc 2 Man 3 GlcNAc 2 , and GlcNAc 1 Man 4 GlcNAc 2 .

12. A whole transgenic plant regenerated from the plant cell of claim 8 wherein said plant comprises said nucleic acid sequence encoding an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine.

13. A transgenic seed produced by the plant of claim 12 wherein said seed comprises said nucleic acid sequence encoding an enzyme capable of performing a transfer reaction of a galactose residue to a non-reducing terminal acetylglucosamine.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2012
From: FUJIYAMA, KAZUHITO; SEKI, TATSUJI; YOSHIDA, TOSHIOMI
To: THE DOW CHEMICAL COMPANY
Reel/Frame 027951/0738 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2012
From: THE DOW CHEMICAL COMPANY
To: DFB BIOTECH, INC.
Reel/Frame 027951/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2012
From: FUJIYAMA, KAZUHITO; SEKI, TATSUJI
To: DFB BIOTECH INC.
Reel/Frame 027951/0773 →
CHANGE OF NAME Recorded Mar 29, 2012
From: DFB BIOTECH, INC.
To: PHYTON, INC.
Reel/Frame 027956/0620 →
CHANGE OF NAME Recorded Mar 29, 2012
From: PHYTON, INC.
To: PHYTON HOLDINGS, LLC
Reel/Frame 027956/0628 →
Priority Claims (1)
JP 2001-12519 · Jan 19, 2001 · national
Continuity (3)
Continuation 11717956 · Mar 14, 2007
Continuation 10466941
Related Publication 20120060239A1 · Mar 8, 2012